Andrew S. Boyer - Aug 14, 2024 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role: Executive Vice President
Signature: /s/ Denis Butkovic, Attorney-in-Fact
Stock symbol: AMRX
Transactions as of: Aug 14, 2024
Transactions value $: -$491,382
Form type: 4
Date filed: 8/16/2024, 04:18 PM
Previous filing: Mar 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMRX	Class A Common Stock	Sale	-$176K	-22.5K	-7.04%	$7.81	297K	Aug 14, 2024	Direct	F1
transaction	AMRX	Class A Common Stock	Sale	-$316K	-40.2K	-13.55%	$7.85	257K	Aug 15, 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 per share to $7.84 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 per share to $7.92 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 per share to $7.84 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 per share to $7.92 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.